| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.52 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.004 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |